Tags: Drug.

Capromorelin (CP-424391) is an investigational medication developed by the Pfizer drug company. It functions as a growth hormone secretagogue and ghrelin mimetic which causes the body to secrete human growth hormone in a way usually seen at puberty and in young adulthood.

Capromorelin_skeletal.svg
ATC prefix
none
CAS number
193273-66-4
FDA UNII code
0MQ44VUN84
IUPAC name
N-[(2R)-1-[(3aR)-2-methyl-3-oxo-3a-(phenylmethyl)-67-dihydro-4H-pyrazolo[43-c]pyridin-5-yl]-1-oxo-3-(phenylmethoxy)propan-2-yl]-2-amino-2-methylpropanamide
PubChem
216208

Loading...

This page contains content from the copyrighted Wikipedia article "Capromorelin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.